Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade TherapyChristina Pfirschke, Mikaël J. Pittet, Camilla Engblom et al.|Immunity|2016Cited by 954
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeNicolas Jacquelot, Laurence Zitvogel, Gladys Ferrere et al.|Cell Research|2019Cited by 246
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancerAlexandre Ivagnès, Laurence Zitvogel, Meriem Messaoudene et al.|OncoImmunology|2017Cited by 42